0000000000799951

AUTHOR

Greg E. Amidon

showing 1 related works from this author

The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC

2013

The Biopharmaceutics Classification System (BCS) has found widespread utility in drug discovery, product development and drug product regulatory sciences. The classification scheme captures the two most significant factors influencing oral drug absorption; solubility and intestinal permeability and it has proven to be a very useful and a widely accepted starting point for drug product development and drug product regulation. The mechanistic base of the BCS approach has, no doubt, contributed to its wide spread acceptance and utility. Nevertheless, underneath the simplicity of BCS are many detailed complexities, both in vitro and in vivo which must be evaluated and investigated for any given…

Drugmedia_common.quotation_subjectAdministration OralPharmaceutical ScienceComputational biologyPharmacologyModels BiologicalPermeabilityArticleIntestinal absorptionQuality by DesignDosage formBiopharmaceuticsIVIVCIn vivoTerminology as TopicAnimalsHumansTechnology PharmaceuticalComputer SimulationPharmacokineticsIntestinal Mucosamedia_commonChemistryBiopharmaceuticsReproducibility of ResultsHydrogen-Ion ConcentrationBiopharmaceutics Classification SystemIntestinal AbsorptionPharmaceutical PreparationsSolubilityEuropean Journal of Pharmaceutical Sciences
researchProduct